The Department of Defense (DoD) is offering this grant, the Peer Reviewed Cancer Collaborative Translational Science Award, to foster synergistic collaborations between clinicians and laboratory scientists. This award aims to accelerate promising research ideas in melanoma and other skin cancers into clinical applications, specifically for service members deployed in high-exposure areas. It supports new and established scientists focusing on understanding molecular/immunological effects of UV and genetic susceptibility. This grant is for research projects that have significant military relevance and involves two to three independent investigators. The ultimate goal is to move laboratory observations into clinical practice, supporting preclinical studies, correlative studies, and the development of clinical endpoints, ensuring a reciprocal flow of ideas from bench to bedside and vice-versa.
Opportunity ID: 48120
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | W81XWH-09-PRCRP-CTS |
| Funding Opportunity Title: | DoD Peer Reviewed Cancer Collaborative Translational Science Award |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement Grant |
| Category of Funding Activity: | Science and Technology and other Research and Development |
| Category Explanation: | – |
| Expected Number of Awards: | 3 |
| Assistance Listings: | 12.420 — Military Medical Research and Development |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 5 |
| Posted Date: | Jun 25, 2009 |
| Last Updated Date: | Aug 29, 2009 |
| Original Closing Date for Applications: | Dec 09, 2009 |
| Current Closing Date for Applications: | Dec 09, 2009 |
| Archive Date: | Jan 08, 2010 |
| Estimated Total Program Funding: | $3,400,000 |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” |
| Additional Information on Eligibility: | – |
Additional Information
| Agency Name: | Dept. of the Army — USAMRAA |
| Description: | The key initiative of the Collaborative Translational Science Award is to encouragecollaborations among clinicians and laboratory scientists that accelerate the movement ofpromising ideas in melanoma and other skin cancers into clinical applications. This award isintended to support both new and established scientists across a broad spectrum of disciplines inresearch projects that are likely to make a major impact on melanoma and other skin cancers forthose service members (and their families) deployed in areas of high exposure. No other topicareas will be allowed.The FY09 PRCRP Collaborative Translational Science Award requests applications fromthese Focus Areas only:Research into melanoma and other skin cancers related to deployments of service members toareas of high exposure by: Understanding molecular and immunological effects of UV at the level of the cell andat the level of the human host. The genetic epidemiology and increased susceptibility to melanoma and other skincancers.DOD Peer Reviewed Cancer Research Program Collaborative Translational Science Award 3Applications to the FY09 PRCRP Collaborative Translational Science Award will be rated ontheir responsiveness to these Focus Areas. It is the responsibility of the applicant to clearlyand explicitly articulate the projects military relevance.The Collaborative Translational Research Award supports the development of translationalresearch collaborations among two or three independent investigators (known as partners) toaddress one of the Focus Areas in melanoma and other skin cancers in a manner relevant tomilitary service that would be less readily achievable through separate efforts. At least onepartner must have experience either in melanoma/other skin cancer research or inmelanoma/other skin cancer patient care. It should be clear that all partners have equalintellectual input into the design of the research project. A proposed project in which one of thepartners merely supplies tissue samples or access to patients will not meet the intent of thismechanism.Observations that drive a research idea may be derived from a laboratory discovery, populationbasedstudies, or a clinicians firsthand knowledge of patients and anecdotal data. The ultimategoal of translational research is to move an observation forward into the clinical application. TheCollaborative Translational Science Award supports preclinical studies in animal models andhuman subjects and human anatomical substances, correlative studies that are associated with anexisting clinical trial, and projects that develop clinical endpoints for clinical trials. Developingthe research plan must involve a reciprocal flow of ideas and information within the researchteam (from bench to bedside, and from bedside to bench). |
| Link to Additional Information: | – |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
PA HELP: 301-619-7079; cdmrp.pa@amedd.army.mil
eReceipt HELP: 301-682-5507; help@cdmrp.org Email:cdmrp.pa@amedd.army.mil |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
| The purpose of this modification is to revise the number of potential attachments to be uploaded under the Attachments Form of the application. The Program Announcement and Application Instructions & General Information documents have been revised accordingly. | Aug 29, 2009 | |
| The purpose of this modification is to revise the number of potential attachments to be uploaded under the Attachments Form of the application. The Program Announcement and Application Instructions & General Information documents have been revised accordingly. | Aug 29, 2009 | |
| Corrected name of Opportunity Title to "DoD Peer Reviewed Cancer Collaborative Translational Science Award." | Aug 29, 2009 | |
| Corrected name of Opportunity Title to "DoD Peer Reviewed Cancer Collaborative Translational Science Award." | Jul 16, 2009 | |
| Jul 16, 2009 |
DISPLAYING: Synopsis 5
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | W81XWH-09-PRCRP-CTS |
| Funding Opportunity Title: | DoD Peer Reviewed Cancer Collaborative Translational Science Award |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement Grant |
| Category of Funding Activity: | Science and Technology and other Research and Development |
| Category Explanation: | – |
| Expected Number of Awards: | 3 |
| Assistance Listings: | 12.420 — Military Medical Research and Development |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 5 |
| Posted Date: | Jun 25, 2009 |
| Last Updated Date: | Aug 29, 2009 |
| Original Closing Date for Applications: | Dec 09, 2009 |
| Current Closing Date for Applications: | Dec 09, 2009 |
| Archive Date: | Jan 08, 2010 |
| Estimated Total Program Funding: | $3,400,000 |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” |
| Additional Information on Eligibility: | – |
Additional Information
| Agency Name: | Dept. of the Army — USAMRAA |
| Description: | The key initiative of the Collaborative Translational Science Award is to encouragecollaborations among clinicians and laboratory scientists that accelerate the movement ofpromising ideas in melanoma and other skin cancers into clinical applications. This award isintended to support both new and established scientists across a broad spectrum of disciplines inresearch projects that are likely to make a major impact on melanoma and other skin cancers forthose service members (and their families) deployed in areas of high exposure. No other topicareas will be allowed.The FY09 PRCRP Collaborative Translational Science Award requests applications fromthese Focus Areas only:Research into melanoma and other skin cancers related to deployments of service members toareas of high exposure by: Understanding molecular and immunological effects of UV at the level of the cell andat the level of the human host. The genetic epidemiology and increased susceptibility to melanoma and other skincancers.DOD Peer Reviewed Cancer Research Program Collaborative Translational Science Award 3Applications to the FY09 PRCRP Collaborative Translational Science Award will be rated ontheir responsiveness to these Focus Areas. It is the responsibility of the applicant to clearlyand explicitly articulate the projects military relevance.The Collaborative Translational Research Award supports the development of translationalresearch collaborations among two or three independent investigators (known as partners) toaddress one of the Focus Areas in melanoma and other skin cancers in a manner relevant tomilitary service that would be less readily achievable through separate efforts. At least onepartner must have experience either in melanoma/other skin cancer research or inmelanoma/other skin cancer patient care. It should be clear that all partners have equalintellectual input into the design of the research project. A proposed project in which one of thepartners merely supplies tissue samples or access to patients will not meet the intent of thismechanism.Observations that drive a research idea may be derived from a laboratory discovery, populationbasedstudies, or a clinicians firsthand knowledge of patients and anecdotal data. The ultimategoal of translational research is to move an observation forward into the clinical application. TheCollaborative Translational Science Award supports preclinical studies in animal models andhuman subjects and human anatomical substances, correlative studies that are associated with anexisting clinical trial, and projects that develop clinical endpoints for clinical trials. Developingthe research plan must involve a reciprocal flow of ideas and information within the researchteam (from bench to bedside, and from bedside to bench). |
| Link to Additional Information: | – |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
PA HELP: 301-619-7079; cdmrp.pa@amedd.army.mil
eReceipt HELP: 301-682-5507; help@cdmrp.org Email:cdmrp.pa@amedd.army.mil |
DISPLAYING: Synopsis 4
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | W81XWH-09-PRCRP-CTS |
| Funding Opportunity Title: | DoD Peer Reviewed Cancer Collaborative Translational Science Award |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement Grant |
| Category of Funding Activity: | Science and Technology and other Research and Development |
| Category Explanation: | – |
| Expected Number of Awards: | 3 |
| Assistance Listings: | 12.420 — Military Medical Research and Development |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 4 |
| Posted Date: | Aug 29, 2009 |
| Last Updated Date: | – |
| Original Closing Date for Applications: | – |
| Current Closing Date for Applications: | Dec 09, 2009 |
| Archive Date: | Jan 08, 2010 |
| Estimated Total Program Funding: | $3,400,000 |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” |
| Additional Information on Eligibility: | – |
Additional Information
| Agency Name: | Dept. of the Army — USAMRAA |
| Description: | The key initiative of the Collaborative Translational Science Award is to encouragecollaborations among clinicians and laboratory scientists that accelerate the movement ofpromising ideas in melanoma and other skin cancers into clinical applications. This award isintended to support both new and established scientists across a broad spectrum of disciplines inresearch projects that are likely to make a major impact on melanoma and other skin cancers forthose service members (and their families) deployed in areas of high exposure. No other topicareas will be allowed.The FY09 PRCRP Collaborative Translational Science Award requests applications fromthese Focus Areas only:Research into melanoma and other skin cancers related to deployments of service members toareas of high exposure by: Understanding molecular and immunological effects of UV at the level of the cell andat the level of the human host. The genetic epidemiology and increased susceptibility to melanoma and other skincancers.DOD Peer Reviewed Cancer Research Program Collaborative Translational Science Award 3Applications to the FY09 PRCRP Collaborative Translational Science Award will be rated ontheir responsiveness to these Focus Areas. It is the responsibility of the applicant to clearlyand explicitly articulate the projects military relevance.The Collaborative Translational Research Award supports the development of translationalresearch collaborations among two or three independent investigators (known as partners) toaddress one of the Focus Areas in melanoma and other skin cancers in a manner relevant tomilitary service that would be less readily achievable through separate efforts. At least onepartner must have experience either in melanoma/other skin cancer research or inmelanoma/other skin cancer patient care. It should be clear that all partners have equalintellectual input into the design of the research project. A proposed project in which one of thepartners merely supplies tissue samples or access to patients will not meet the intent of thismechanism.Observations that drive a research idea may be derived from a laboratory discovery, populationbasedstudies, or a clinicians firsthand knowledge of patients and anecdotal data. The ultimategoal of translational research is to move an observation forward into the clinical application. TheCollaborative Translational Science Award supports preclinical studies in animal models andhuman subjects and human anatomical substances, correlative studies that are associated with anexisting clinical trial, and projects that develop clinical endpoints for clinical trials. Developingthe research plan must involve a reciprocal flow of ideas and information within the researchteam (from bench to bedside, and from bedside to bench). |
| Link to Additional Information: | – |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
PA HELP: 301-619-7079; cdmrp.pa@amedd.army.mil
eReceipt HELP: 301-682-5507; help@cdmrp.org Email:cdmrp.pa@amedd.army.mil |
DISPLAYING: Synopsis 3
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | W81XWH-09-PRCRP-CTS |
| Funding Opportunity Title: | DoD Peer Reviewed Cancer Collaborative Translational Science Award |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement Grant |
| Category of Funding Activity: | Science and Technology and other Research and Development |
| Category Explanation: | – |
| Expected Number of Awards: | 3 |
| Assistance Listings: | 12.420 — Military Medical Research and Development |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 3 |
| Posted Date: | Aug 29, 2009 |
| Last Updated Date: | – |
| Original Closing Date for Applications: | – |
| Current Closing Date for Applications: | Dec 09, 2009 |
| Archive Date: | Jan 08, 2010 |
| Estimated Total Program Funding: | $3,400,000 |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” |
| Additional Information on Eligibility: | – |
Additional Information
| Agency Name: | Dept. of the Army — USAMRAA |
| Description: | The key initiative of the Collaborative Translational Science Award is to encouragecollaborations among clinicians and laboratory scientists that accelerate the movement ofpromising ideas in melanoma and other skin cancers into clinical applications. This award isintended to support both new and established scientists across a broad spectrum of disciplines inresearch projects that are likely to make a major impact on melanoma and other skin cancers forthose service members (and their families) deployed in areas of high exposure. No other topicareas will be allowed.The FY09 PRCRP Collaborative Translational Science Award requests applications fromthese Focus Areas only:Research into melanoma and other skin cancers related to deployments of service members toareas of high exposure by: Understanding molecular and immunological effects of UV at the level of the cell andat the level of the human host. The genetic epidemiology and increased susceptibility to melanoma and other skincancers.DOD Peer Reviewed Cancer Research Program Collaborative Translational Science Award 3Applications to the FY09 PRCRP Collaborative Translational Science Award will be rated ontheir responsiveness to these Focus Areas. It is the responsibility of the applicant to clearlyand explicitly articulate the projects military relevance.The Collaborative Translational Research Award supports the development of translationalresearch collaborations among two or three independent investigators (known as partners) toaddress one of the Focus Areas in melanoma and other skin cancers in a manner relevant tomilitary service that would be less readily achievable through separate efforts. At least onepartner must have experience either in melanoma/other skin cancer research or inmelanoma/other skin cancer patient care. It should be clear that all partners have equalintellectual input into the design of the research project. A proposed project in which one of thepartners merely supplies tissue samples or access to patients will not meet the intent of thismechanism.Observations that drive a research idea may be derived from a laboratory discovery, populationbasedstudies, or a clinicians firsthand knowledge of patients and anecdotal data. The ultimategoal of translational research is to move an observation forward into the clinical application. TheCollaborative Translational Science Award supports preclinical studies in animal models andhuman subjects and human anatomical substances, correlative studies that are associated with anexisting clinical trial, and projects that develop clinical endpoints for clinical trials. Developingthe research plan must involve a reciprocal flow of ideas and information within the researchteam (from bench to bedside, and from bedside to bench). |
| Link to Additional Information: | – |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
PA HELP: 301-619-7079; cdmrp.pa@amedd.army.mil
eReceipt HELP: 301-682-5507; help@cdmrp.org Email:cdmrp.pa@amedd.army.mil |
DISPLAYING: Synopsis 2
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | W81XWH-09-PRCRP-CTS |
| Funding Opportunity Title: | DoD Peer Reviewed Cancer Collaborative Translational Science Award |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement Grant |
| Category of Funding Activity: | Science and Technology and other Research and Development |
| Category Explanation: | – |
| Expected Number of Awards: | 3 |
| Assistance Listings: | 12.420 — Military Medical Research and Development |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 2 |
| Posted Date: | Jul 16, 2009 |
| Last Updated Date: | – |
| Original Closing Date for Applications: | – |
| Current Closing Date for Applications: | Dec 09, 2009 |
| Archive Date: | Jan 08, 2010 |
| Estimated Total Program Funding: | $3,400,000 |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” |
| Additional Information on Eligibility: | – |
Additional Information
| Agency Name: | Dept. of the Army — USAMRAA |
| Description: | The key initiative of the Collaborative Translational Science Award is to encourage collaborations among clinicians and laboratory scientists that accelerate the movement of promising ideas in melanoma and other skin cancers into clinical applications. This award is intended to support both new and established scientists across a broad spectrum of disciplines in research projects that are likely to make a major impact on melanoma and other skin cancers for those service members (and their families) deployed in areas of high exposure. No other topic areas will be allowed. The FY09 PRCRP Collaborative Translational Science Award requests applications from these Focus Areas only: Research into melanoma and other skin cancers related to deployments of service members to areas of high exposure by: Understanding molecular and immunological effects of UV at the level of the cell and at the level of the human host. The genetic epidemiology and increased susceptibility to melanoma and other skin cancers. DOD Peer Reviewed Cancer Research Program Collaborative Translational Science Award 3 Applications to the FY09 PRCRP Collaborative Translational Science Award will be rated on their responsiveness to these Focus Areas. It is the responsibility of the applicant to clearly and explicitly articulate the projects military relevance. The Collaborative Translational Research Award supports the development of translational research collaborations among two or three independent investigators (known as partners) to address one of the Focus Areas in melanoma and other skin cancers in a manner relevant to military service that would be less readily achievable through separate efforts. At least one partner must have experience either in melanoma/other skin cancer research or in melanoma/other skin cancer patient care. It should be clear that all partners have equal intellectual input into the design of the research project. A proposed project in which one of the partners merely supplies tissue samples or access to patients will not meet the intent of this mechanism. Observations that drive a research idea may be derived from a laboratory discovery, populationbased studies, or a clinicians firsthand knowledge of patients and anecdotal data. The ultimate goal of translational research is to move an observation forward into the clinical application. The Collaborative Translational Science Award supports preclinical studies in animal models and human subjects and human anatomical substances, correlative studies that are associated with an existing clinical trial, and projects that develop clinical endpoints for clinical trials. Developing the research plan must involve a reciprocal flow of ideas and information within the research team (from bench to bedside, and from bedside to bench). |
| Link to Additional Information: | – |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
PA HELP: 301-619-7079; cdmrp.pa@amedd.army.mil
eReceipt HELP: 301-682-5507; help@cdmrp.org Email:cdmrp.pa@amedd.army.mil |
DISPLAYING: Synopsis 1
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | W81XWH-09-PRCRP-CTS |
| Funding Opportunity Title: | DoD Peer Reviewed Cancer Collaboratrive Translational Science Award |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement Grant |
| Category of Funding Activity: | Science and Technology and other Research and Development |
| Category Explanation: | – |
| Expected Number of Awards: | 3 |
| Assistance Listings: | 12.420 — Military Medical Research and Development |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Jul 16, 2009 |
| Last Updated Date: | – |
| Original Closing Date for Applications: | – |
| Current Closing Date for Applications: | Dec 09, 2009 |
| Archive Date: | Jan 08, 2010 |
| Estimated Total Program Funding: | $3,400,000 |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” |
| Additional Information on Eligibility: | – |
Additional Information
| Agency Name: | Dept. of the Army — USAMRAA |
| Description: | The key initiative of the Collaborative Translational Science Award is to encourage collaborations among clinicians and laboratory scientists that accelerate the movement of promising ideas in melanoma and other skin cancers into clinical applications. This award is intended to support both new and established scientists across a broad spectrum of disciplines in research projects that are likely to make a major impact on melanoma and other skin cancers for those service members (and their families) deployed in areas of high exposure. No other topic areas will be allowed. The FY09 PRCRP Collaborative Translational Science Award requests applications from these Focus Areas only: Research into melanoma and other skin cancers related to deployments of service members to areas of high exposure by: Understanding molecular and immunological effects of UV at the level of the cell and at the level of the human host. The genetic epidemiology and increased susceptibility to melanoma and other skin cancers. DOD Peer Reviewed Cancer Research Program Collaborative Translational Science Award 3 Applications to the FY09 PRCRP Collaborative Translational Science Award will be rated on their responsiveness to these Focus Areas. It is the responsibility of the applicant to clearly and explicitly articulate the projects military relevance. The Collaborative Translational Research Award supports the development of translational research collaborations among two or three independent investigators (known as partners) to address one of the Focus Areas in melanoma and other skin cancers in a manner relevant to military service that would be less readily achievable through separate efforts. At least one partner must have experience either in melanoma/other skin cancer research or in melanoma/other skin cancer patient care. It should be clear that all partners have equal intellectual input into the design of the research project. A proposed project in which one of the partners merely supplies tissue samples or access to patients will not meet the intent of this mechanism. Observations that drive a research idea may be derived from a laboratory discovery, populationbased studies, or a clinicians firsthand knowledge of patients and anecdotal data. The ultimate goal of translational research is to move an observation forward into the clinical application. The Collaborative Translational Science Award supports preclinical studies in animal models and human subjects and human anatomical substances, correlative studies that are associated with an existing clinical trial, and projects that develop clinical endpoints for clinical trials. Developing the research plan must involve a reciprocal flow of ideas and information within the research team (from bench to bedside, and from bedside to bench). |
| Link to Additional Information: | – |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
PA HELP: 301-619-7079; cdmrp.pa@amedd.army.mil
eReceipt HELP: 301-682-5507; help@cdmrp.org Email:cdmrp.pa@amedd.army.mil |
Related Documents
Folder 48120 Full Announcement-1 -> fy09 prcrp cts award pa – final-environment0825.pdf
Folder 48120 Full Announcement-1 -> biosketchjune09.pdf
Folder 48120 Full Announcement-1 -> budget form reader.pdf
Packages
| Agency Contact Information: | PA HELP: 301-619-7079; cdmrp.pa@amedd.army.mil eReceipt HELP: 301-682-5507; help@cdmrp.org Email: cdmrp.pa@amedd.army.mil |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| 12.420 | PKG00012753 | Jun 25, 2009 | Dec 09, 2009 | View |
Package 1
Mandatory forms
48120 RR_SF424-1.1.pdf
48120 RR_PerformanceSite-1.1.pdf
Optional forms
48120 RR_KeyPersonExpanded-1.1.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
